Overview

Carbetocin Versus Ergometrin in the Prevention of Postpartum Hemorrhage

Status:
Recruiting
Trial end date:
2020-09-30
Target enrollment:
Participant gender:
Summary
In the present study will be compared Carbetocin with ergometrin in the prevention of postpartum haemorrhage (PPH) in parturients that are undergoing caesarean section and are not presenting risk factors for PPH. As indicators will be used intraoperative blood loss, as well as the value of hemoglobin and hematocrit 24 hours after the caesarian section.
Phase:
Phase 4
Details
Lead Sponsor:
National and Kapodistrian University of Athens
Treatments:
Carbetocin
Ergonovine
Maleic acid
Oxytocin